版本:
中国

BRIEF-Replicel's phase 1 clinical trial for hair loss meets primary endpoints

March 14 Replicel Life Sciences Inc

* Replicel's phase 1 clinical trial for hair loss succeeds in meeting primary endpoints

* Replicel life sciences - trial succesfully met its endpoints and sets stage for next steps in ongoing research and development of its product, rch-01 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐